Morgan Stanley’s iPath Pure Beta Livestock ETN LSTK Stock Holding History

Morgan Stanley’s Portfolio LSTK Stock Details LSTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-175	Closed	-$7K	–	6837
2017 Q1	$7K	Hold	175	–	–	﹤0.01%	6317
2016 Q4	$7K	Buy	+175	New	+$6.44K	﹤0.01%	6243

Other funds holding LSTK

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NewSquare Capital Newtown Square, Pennsylvania $1.15B AUM 24.78% 1-Year Est. Return

Morgan Stanley's LSTK Position: Q2 2017 in Review

Morgan Stanley sold out of iPath Pure Beta Livestock ETN (LSTK) in Q2 2017, closing a stake of 175 shares — an estimated $7K sold.

Morgan Stanley first reported a position in LSTK in Q4 2016 and held it in 2 quarters. The position peaked at $7K in Q1 2017. 4 funds tracked by Wall St. Rank hold LSTK as of Q2 2017.

Morgan Stanley reported no remaining iPath Pure Beta Livestock ETN position as of Q2 2017 after selling out during the quarter.
Morgan Stanley sold 175 iPath Pure Beta Livestock ETN shares in Q2 2017, an estimated $7K.
Morgan Stanley first reported a position in iPath Pure Beta Livestock ETN in Q4 2016 and held it in 2 quarters.
Morgan Stanley's iPath Pure Beta Livestock ETN position peaked at $7K in Q1 2017.
4 funds tracked by Wall St. Rank held iPath Pure Beta Livestock ETN as of Q2 2017.

Based on Morgan Stanley's 13F filing for Q2 2017, filed 11 Aug 2017.